These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1689142)

  • 1. Improved detection of metastases to lymph nodes and estrogen receptor determination.
    Schurman SH; Sharon N; Goldschmidt RA; Scanlon EF
    Arch Surg; 1990 Feb; 125(2):179-82. PubMed ID: 1689142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection and significance of axillary lymph node micrometastases in breast carcinoma. A study of 97 cases.
    Elson CE; Kufe D; Johnston WW
    Anal Quant Cytol Histol; 1993 Jun; 15(3):171-8. PubMed ID: 7688511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of estrogen and progesterone receptors in primary tumor and lymph nodes in individual patients with breast cancer.
    Coradini D; Cappelletti V; Miodini P; Ronchi E; Scavone G; Di Fronzo G
    Tumori; 1984 Apr; 70(2):165-8. PubMed ID: 6730015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
    Zhang JG; Zhong L; Li CL
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
    [No Abstract]   [Full Text] [Related]  

  • 5. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
    Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
    J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer.
    Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y
    Cancer; 1991 Nov; 68(9):1918-25. PubMed ID: 1655229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer primary tumor ER expression pattern predicts its expression concordance in matched synchronous lymph node metastases.
    Zhao J; Hu C; Wang C; Yu W; Guo Y; Shi M; Shui Y; Wei Q
    BMC Cancer; 2018 Dec; 18(1):1290. PubMed ID: 30587150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the detection of breast carcinoma metastases by routine histological diagnosis and by immunohistochemical staining.
    Berry N; Jones DB; Marshall R; Smallwood J; Taylor I
    Eur Surg Res; 1988; 20(4):225-32. PubMed ID: 2458931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biological significance of estrogen receptor status in axillary lymph node metastases of invasive ductal breast cancers].
    Horst HA; Horny HP; Gent HJ; Sellschopp C; Hedderich J
    Klin Wochenschr; 1988 Dec; 66(23):1160-6. PubMed ID: 2850408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction.
    Noguchi S; Aihara T; Motomura K; Inaji H; Imaoka S; Koyama H
    Cancer; 1996 Sep; 78(6):1235-40. PubMed ID: 8826945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study.
    Dowlatshahi K; Fan M; Bloom KJ; Spitz DJ; Patel S; Snider HC
    Cancer; 1999 Sep; 86(6):990-6. PubMed ID: 10491525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoperoxidase staining in the detection of lymph node metastases in stage I breast cancer.
    Raymond WA; Leong AS
    Pathology; 1989 Jan; 21(1):11-5. PubMed ID: 2474791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic mastectomy in patients at high risk: is there a role for sentinel lymph node biopsy?
    Murthy V; Chamberlain RS
    Clin Breast Cancer; 2013 Jun; 13(3):180-7. PubMed ID: 23357305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary tumour characteristics and axillary lymph node status in breast cancer.
    Yiangou C; Shousha S; Sinnett HD
    Br J Cancer; 1999 Aug; 80(12):1974-8. PubMed ID: 10471048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occult metastases in the axillary lymph nodes of patients with breast cancer node negative by clinical and histologic examination and conventional histology.
    Chen ZL; Wen DR; Coulson WF; Giuliano AE; Cochran AJ
    Dis Markers; 1991; 9(5):239-48. PubMed ID: 1724633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Micrometastases of the axillary lymph nodes in breast cancer. An immunohistochemical study].
    Ronay G; Tomesch A; Tulusan AH
    Pathologe; 1989 Sep; 10(5):289-93. PubMed ID: 2477837
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of micrometastases in sentinel lymph nodes of the breast applying monoclonal antibodies AE1/AE3 to pancytokeratins.
    Kowolik JH; Kuhn W; Nährig J; Werner M; Obst T; Avril N; Schmitt M; Graeff H
    Oncol Rep; 2000; 7(4):745-9. PubMed ID: 10854537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult axillary lymph node metastases discovered by serial section in node-negative breast cancer.
    Karalak A; Homcha-Em P
    J Med Assoc Thai; 1999 Oct; 82(10):1017-9. PubMed ID: 10561965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical significance of cytokeratin-positive cells in lymph nodes at the time of mastectomy from patients with ductal carcinoma-in-situ.
    Tamhane R; Dahlstrom JE; McCallum DD; Buckingham JM
    Ann Surg Oncol; 2002 Dec; 9(10):999-1003. PubMed ID: 12464593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
    Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
    JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.